Cargando…
Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain
AIMS: The aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799925/ https://www.ncbi.nlm.nih.gov/pubmed/26613544 http://dx.doi.org/10.1111/bcp.12850 |